Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ICU MEDICAL INC/DEICUI · Entity 2385 | Chief Financial Officer | September 01, 2026 | September 01, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ICU MEDICAL INC/DE
Report date September 01, 2026 · Filed September 01, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 56,062 |
Reported balance
After 2026-09-01 transaction · row 1
1 source rowRow 1 · 2026-09-01 · Sale · Disposed 6,381 · Balance 56,062 F1: The restricted award sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2026. F2: All shares sold were sold at the exact price disclosed. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted award sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2026.
F2: All shares sold were sold at the exact price disclosed.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 01, 2026 Filed Sep 1, 2026 21:21 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 6,381 | $175.00 | $1,116,675.00 |
DisclosureSEC source: 0001804831-26-000006 · edgardoc.xml · nonDerivative · entry 1 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,062 F1 · shares: The restricted award sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2026. F2 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| August 31, 2026 Filed Aug 31, 2026 20:43 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 1,113 | $173.91 | $193,566.73 |
DisclosureSEC source: 0001804831-26-000005 · edgardoc.xml · nonDerivative · entry 4 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 62,443 F1 · shares: The restricted award sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2026. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $173.77 to $174.08, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| August 31, 2026 Filed Aug 31, 2026 20:43 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 4,568 | $173.44 | $792,290.82 |
DisclosureSEC source: 0001804831-26-000005 · edgardoc.xml · nonDerivative · entry 3 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 63,556 F1 · shares: The restricted award sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2026. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $172.69 to $173.765, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| August 31, 2026 Filed Aug 31, 2026 20:43 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 1,914 | $172.12 | $329,442.66 |
DisclosureSEC source: 0001804831-26-000005 · edgardoc.xml · nonDerivative · entry 2 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 68,124 F1 · shares: The restricted award sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2026. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $171.625 to $172.6, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| August 31, 2026 Filed Aug 31, 2026 20:43 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 1,712 | $171.05 | $292,843.08 |
DisclosureSEC source: 0001804831-26-000005 · edgardoc.xml · nonDerivative · entry 1 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 70,038 F1 · shares: The restricted award sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2026. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $170.57 to $171.495, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| March 15, 2026 Filed Mar 16, 2026 20:28 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionPerformance Shares · Derivative | 11,400 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001804831-26-000004 · edgardoc.xml · derivative · entry 6 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,400 shares Expires 2026-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These Securities are Performance-based Restricted Stock Units (PRSU). F5 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs. F2 · shares: Represents the settlement of performance stock units granted on 3/15/2023. Upon the certification of performance results by the Compensation Committee on 2/11/26, the PRSUs were earned at 117% of target, resulting in the acquisition of the shares reported herein. Read SEC document |
| March 15, 2026 Filed Mar 16, 2026 20:28 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 3,248 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001804831-26-000004 · edgardoc.xml · derivative · entry 5 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,248 shares Expires 2026-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: These securities are Restricted Stock Units. F4 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. Read SEC document |
| March 15, 2026 Filed Mar 16, 2026 20:28 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 1,795 | $125.85 | $225,900.75 |
DisclosureSEC source: 0001804831-26-000004 · edgardoc.xml · nonDerivative · entry 4 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,750 Read SEC document |
| March 15, 2026 Filed Mar 16, 2026 20:28 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 3,248 | $0.00 | $0.00 |
DisclosureSEC source: 0001804831-26-000004 · edgardoc.xml · nonDerivative · entry 3 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,545 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: These securities are Restricted Stock Units. Read SEC document |
| March 15, 2026 Filed Mar 16, 2026 20:28 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 5,800 | $125.85 | $729,930.00 |
DisclosureSEC source: 0001804831-26-000004 · edgardoc.xml · nonDerivative · entry 2 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,297 F1 · security: These Securities are Performance-based Restricted Stock Units (PRSU). Read SEC document |
| March 15, 2026 Filed Mar 16, 2026 20:28 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 11,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001804831-26-000004 · edgardoc.xml · nonDerivative · entry 1 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,097 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These Securities are Performance-based Restricted Stock Units (PRSU). F2 · shares: Represents the settlement of performance stock units granted on 3/15/2023. Upon the certification of performance results by the Compensation Committee on 2/11/26, the PRSUs were earned at 117% of target, resulting in the acquisition of the shares reported herein. Read SEC document |
| March 08, 2026 Filed Mar 9, 2026 20:32 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionPerformance Shares · Derivative | 71,757 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001804831-26-000003 · edgardoc.xml · derivative · entry 6 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 71,757 shares Expires 2026-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: These Securities are Performance-based Restricted Stock Units (PRSU). F7 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs. F2 · shares: Represents the settlement of performance stock units granted on 3/8/2024. Upon the certification of performance results by the Compensation Committee on 2/11/26, the PRSUs were earned at 250% of target, resulting in the acquisition of the shares reported herein. Read SEC document |
| March 08, 2026 Filed Mar 9, 2026 20:32 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 39,667 | $132.00 | $5,236,044.00 |
DisclosureSEC source: 0001804831-26-000003 · edgardoc.xml · nonDerivative · entry 4 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,697 Read SEC document |
| March 08, 2026 Filed Mar 9, 2026 20:32 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 71,757 | $0.00 | $0.00 |
DisclosureSEC source: 0001804831-26-000003 · edgardoc.xml · nonDerivative · entry 3 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,364 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents the settlement of performance stock units granted on 3/8/2024. Upon the certification of performance results by the Compensation Committee on 2/11/26, the PRSUs were earned at 250% of target, resulting in the acquisition of the shares reported herein. Read SEC document |
| March 07, 2026 Filed Mar 9, 2026 20:32 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 3,522 | $0.00 | $0.00 |
DisclosureSEC source: 0001804831-26-000003 · edgardoc.xml · derivative · entry 5 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,044 Underlying: Common Stock · 3,522 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F3 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F4 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F5 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 07, 2026 Filed Mar 9, 2026 20:32 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 1,263 | $0.00 | $0.00 |
DisclosureSEC source: 0001804831-26-000003 · edgardoc.xml · nonDerivative · entry 2 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,607 Read SEC document |
| March 07, 2026 Filed Mar 9, 2026 20:32 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 3,522 | $0.00 | $0.00 |
DisclosureSEC source: 0001804831-26-000003 · edgardoc.xml · nonDerivative · entry 1 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,870 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 00:16 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 3,248 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001804831-25-000002 · edgardoc.xml · derivative · entry 2 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,248 Underlying: Common Stock · 3,248 shares Expires 2026-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F4 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 00:16 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 3,248 | $0.00 | $0.00 |
DisclosureSEC source: 0001804831-25-000002 · edgardoc.xml · nonDerivative · entry 1 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,348 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| March 07, 2025 Filed Mar 10, 2025 23:35 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | GrantCommon Stock · Derivative | 10,566 | $0.00 | $0.00 |
DisclosureSEC source: 0001804831-25-000001 · edgardoc.xml · derivative · entry 3 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,566 Underlying: Common Stock · 10,566 shares Expires not disclosed F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F4 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 07, 2025 Filed Mar 10, 2025 23:35 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 2,146 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001804831-25-000001 · edgardoc.xml · derivative · entry 2 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,146 shares Expires 2025-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F4 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 07, 2025 Filed Mar 10, 2025 23:35 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 2,146 | $0.00 | $0.00 |
DisclosureSEC source: 0001804831-25-000001 · edgardoc.xml · nonDerivative · entry 1 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 20:35 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 3,247 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001804831-24-000002 · edgardoc.xml · derivative · entry 3 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,496 Underlying: Common Stock · 3,247 shares Expires 2026-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. These awards were legally granted on March 15, 2023 but were subject to shareholder approval on May 17, 2023. Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 20:35 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 1,780 | $98.08 | $174,582.40 |
DisclosureSEC source: 0001804831-24-000002 · edgardoc.xml · nonDerivative · entry 2 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,954 Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 20:35 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 3,247 | $0.00 | $0.00 |
DisclosureSEC source: 0001804831-24-000002 · edgardoc.xml · nonDerivative · entry 1 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,734 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:28 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionPerformance Shares · Derivative | 7,289 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001804831-24-000001 · edgardoc.xml · derivative · entry 12 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,289 shares Expires 2024-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: These Securities are Performance-based Restricted Stock Units (PRSU). F6 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs. F8 · derivative.exercise_date: These PRSUs were granted on March 8, 2021 and had a 3-Year cliff-vest subject to the satisfaction of performance-based metrics and continuous services through the vest date. The PRSUs were approved for vesting in February 2024 by the Compensation Committee at 110% of the original grant. Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:28 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 2,210 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001804831-24-000001 · edgardoc.xml · derivative · entry 9 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,210 shares Expires 2024-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F3 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F4 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F5 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:28 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 3,998 | $104.52 | $417,870.96 |
DisclosureSEC source: 0001804831-24-000001 · edgardoc.xml · nonDerivative · entry 8 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,487 Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:28 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 7,289 | $0.00 | $0.00 |
DisclosureSEC source: 0001804831-24-000001 · edgardoc.xml · nonDerivative · entry 7 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,485 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: These Securities are Performance-based Restricted Stock Units (PRSU). Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:28 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 1,212 | $104.52 | $126,678.24 |
DisclosureSEC source: 0001804831-24-000001 · edgardoc.xml · nonDerivative · entry 6 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,196 Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:28 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 2,210 | $0.00 | $0.00 |
DisclosureSEC source: 0001804831-24-000001 · edgardoc.xml · nonDerivative · entry 5 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,408 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 20:28 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionPerformance Shares · Derivative | 12,872 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001804831-24-000001 · edgardoc.xml · derivative · entry 11 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,872 shares Expires 2024-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: These Securities are Performance-based Restricted Stock Units (PRSU). F6 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs. F7 · derivative.exercise_date: These PRSUs were granted on March 7, 2022 and had a 2-year cliff-vest performance period subject to the satisfaction of performance-based metrics and continuous services through the vest date. The PRSUs were approved for vesting in February 2024 by the Compensation Committee at 200% of the original grant. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 20:28 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 2,145 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001804831-24-000001 · edgardoc.xml · derivative · entry 10 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,146 Underlying: Common Stock · 2,145 shares Expires 2025-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F3 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F4 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F5 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 20:28 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 7,059 | $105.39 | $743,948.01 |
DisclosureSEC source: 0001804831-24-000001 · edgardoc.xml · nonDerivative · entry 4 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,198 Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 20:28 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 12,872 | $0.00 | $0.00 |
DisclosureSEC source: 0001804831-24-000001 · edgardoc.xml · nonDerivative · entry 3 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,257 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: These Securities are Performance-based Restricted Stock Units (PRSU). Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 20:28 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 1,175 | $105.39 | $123,833.25 |
DisclosureSEC source: 0001804831-24-000001 · edgardoc.xml · nonDerivative · entry 2 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,385 Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 20:28 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 2,145 | $0.00 | $0.00 |
DisclosureSEC source: 0001804831-24-000001 · edgardoc.xml · nonDerivative · entry 1 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,560 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| May 17, 2023 Filed May 18, 2023 17:28 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | GrantCommon Stock · Derivative | 9,743 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001804831-23-000002 · edgardoc.xml · derivative · entry 1 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,743 Underlying: Common Stock · 9,743 shares Expires 2026-03-15 F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. These awards were legally granted on March 15, 2023 but were subject to shareholder approval on May 17, 2023. Read SEC document |
| March 08, 2023 Filed Mar 8, 2023 21:52 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 2,209 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001804831-23-000001 · edgardoc.xml · derivative · entry 10 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,210 Underlying: Common Stock · 2,209 shares Expires 2024-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F4 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 08, 2023 Filed Mar 8, 2023 21:52 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 1,163 | $156.17 | $181,625.71 |
DisclosureSEC source: 0001804831-23-000001 · edgardoc.xml · nonDerivative · entry 8 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,415 Read SEC document |
| March 08, 2023 Filed Mar 8, 2023 21:52 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 2,209 | $0.00 | $0.00 |
DisclosureSEC source: 0001804831-23-000001 · edgardoc.xml · nonDerivative · entry 7 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,578 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| March 07, 2023 Filed Mar 8, 2023 21:52 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 2,145 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001804831-23-000001 · edgardoc.xml · derivative · entry 11 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,291 Underlying: Common Stock · 2,145 shares Expires 2025-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F4 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 07, 2023 Filed Mar 8, 2023 21:52 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 1,129 | $157.47 | $177,783.63 |
DisclosureSEC source: 0001804831-23-000001 · edgardoc.xml · nonDerivative · entry 6 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,369 Read SEC document |
| March 07, 2023 Filed Mar 8, 2023 21:52 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 2,145 | $0.00 | $0.00 |
DisclosureSEC source: 0001804831-23-000001 · edgardoc.xml · nonDerivative · entry 5 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,498 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 21:52 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionPerformance Shares · Derivative | 8,745 | $0.00 | $0.00 |
DisclosureSEC source: 0001804831-23-000001 · edgardoc.xml · derivative · entry 12 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,745 shares Expires 2023-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: These Securities are Performance-based Restricted Stock Units (PRSU). F6 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs. F7 · derivative.exercise_date: These PRSUs were granted on March 6, 2020 and were subject to the satisfaction of both performance-based and time-based criteria. These PRSUs had a 3-year performance period and cliff-vested on the third anniversary of the grant date. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 21:52 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 1,551 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001804831-23-000001 · edgardoc.xml · derivative · entry 9 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,551 shares Expires 2023-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F4 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 21:52 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 4,604 | $161.25 | $742,395.00 |
DisclosureSEC source: 0001804831-23-000001 · edgardoc.xml · nonDerivative · entry 4 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,353 Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 21:52 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 8,745 | $0.00 | $0.00 |
DisclosureSEC source: 0001804831-23-000001 · edgardoc.xml · nonDerivative · entry 3 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,957 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 21:52 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 816 | $161.25 | $131,580.00 |
DisclosureSEC source: 0001804831-23-000001 · edgardoc.xml · nonDerivative · entry 2 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,212 Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 21:52 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 1,551 | $0.00 | $0.00 |
DisclosureSEC source: 0001804831-23-000001 · edgardoc.xml · nonDerivative · entry 1 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,028 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.